🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of Part 1 of the study were: * To determine the rate of hem...
Status
Completed
Location
Dana Faber Cancer Institute
Start Date
1999-08-09
Trial ID
NCT00171249
Treatments Being Tested
The primary purpose of this study is to estimate the major cytogenetic resp...
Status
Completed
Location
Local Institution
Start Date
2005-02
Trial ID
NCT00103844
The Imatinib Mesylate at a dose of 400 mg / day is the standard treatment f...
Status
Terminated
Location
Institut Bergonié
Start Date
2009-07
Trial ID
NCT01827930
Treatments Being Tested
This trial was a Phase I/II, non-randomized, open label, multi-center study...
Status
Completed
Location
Dana Farber Cancer Institute Dept of Sarcoma Oncology
Start Date
2002-11-13
Trial ID
NCT01275222
This study investigates the efficacy and safety of STI571 for the treatment...
Status
Completed
Location
Novartis Investigator Site
Start Date
2008-01-02
Trial ID
NCT00613171
Treatments Being Tested
This is a Phase III study comparing Imatinib mesylate and hydroxyurea combi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2004-10
Trial ID
NCT00154375
Treatments Being Tested
The purpose of this study is to better characterize the long-term safety of...
Status
Completed
Location
University of California LA
Start Date
2013-03-26
Trial ID
NCT01742299
Treatments Being Tested
This extension II study allowed for further follow-up of the disease under ...
Status
Completed
Location
University of Chicago
Start Date
1999-07-26
Trial ID
NCT00171158
Treatments Being Tested
In this study, adults with newly-diagnosed Philadelphia Chromosome-positive...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-10-04
Trial ID
NCT03589326
Treatments Being Tested
To provide study drug to patients that benefit from treatment judged by the...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2006-11
Trial ID
NCT00441155
Treatments Being Tested